Return to homepagePandemic Pact

Identification and characterization of human monoclonal antibodies neutralizing 2019-nCoV with potential development towards vaccine candidates.

Grant number: THERAMAB

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    INSERM, REACTing

  • Principal Investigator

    Hugo Mouquet

  • Research Location

    France

  • Lead Research Institution

    Institut Pasteur

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Identification and characterization of human monoclonal antibodies neutralizing 2019-nCoV with potential development towards vaccine candidates.